» Articles » PMID: 36422963

Exposure to Low Zearalenone Doses and Changes in the Homeostasis and Concentrations of Endogenous Hormones in Selected Steroid-Sensitive Tissues in Pre-Pubertal Gilts

Overview
Journal Toxins (Basel)
Publisher MDPI
Specialty Toxicology
Date 2022 Nov 24
PMID 36422963
Authors
Affiliations
Soon will be listed here.
Abstract

This study was undertaken to analyze whether prolonged exposure to low-dose zearalenone (ZEN) mycotoxicosis affects the concentrations of ZEN, α-zearalenol (α-ZEL), and β-zearalenol (β-ZEL) in selected reproductive system tissues (ovaries, uterine horn-ovarian and uterine sections, and the middle part of the cervix), the hypothalamus, and pituitary gland, or the concentrations of selected steroid hormones in pre-pubertal gilts. For 42 days, gilts were administered per os different ZEN doses (MABEL dose [5 µg/kg BW], the highest NOAEL dose [10 µg/kg BW], and the lowest LOAEL dose [15 µg/kg BW]). Tissue samples were collected on days seven, twenty-one, and forty-two of exposure to ZEN (exposure days D1, D2, and D3, respectively). Blood for the analyses of estradiol and progesterone concentrations was collected in vivo on six dates at seven-day intervals (on analytical dates D1-D6). The analyses revealed that both ZEN and its metabolites were accumulated in the examined tissues. On successive analytical dates, the rate of mycotoxin accumulation in the studied tissues decreased gradually by 50% and proportionally to the administered ZEN dose. A hierarchical visualization revealed that values of the carry-over factor (CF) were highest on exposure day D2. In most groups and on most exposure days, the highest CF values were found in the middle part of the cervix, followed by the ovaries, both sections of the uterine horn, and the hypothalamus. These results suggest that ZEN, α-ZEL, and β-ZEL were deposited in all analyzed tissues despite exposure to very low ZEN doses. The presence of these undesirable compounds in the examined tissues can inhibit the somatic development of the reproductive system and compromise neuroendocrine coordination of reproductive competence in pre-pubertal gilts.

Citing Articles

Characterization of the Phosphotransferase from 1101 That Is Responsible for the Biotransformation of Zearalenone.

Wu Y, Zhou Q, Hu J, Shan Y, Liu J, Wang G Toxins (Basel). 2025; 17(1).

PMID: 39852973 PMC: 11768653. DOI: 10.3390/toxins17010021.


Toxicokinetics of Zearalenone following Oral Administration in Female Dezhou Donkeys.

Qu H, Zheng Y, Kang R, Feng Y, Li P, Wang Y Toxins (Basel). 2024; 16(1).

PMID: 38251267 PMC: 10819545. DOI: 10.3390/toxins16010051.


A Cohort Study Investigating Zearalenone Concentrations and Selected Steroid Levels in Patients with Sigmoid Colorectal Cancer or Colorectal Cancer.

Lisieska-Zolnierczyk S, Gajecka M, Dabrowski M, Zielonka L, Gajecki M Toxins (Basel). 2024; 16(1).

PMID: 38251232 PMC: 10821418. DOI: 10.3390/toxins16010015.


Oxidative Status and Histological Evaluation of Wild Boars' Tissues Positive for Zearalenone Contamination in the Campania Region, Southern Italy.

Damiano S, Longobardi C, Ferrara G, Piscopo N, Riccio L, Russo V Antioxidants (Basel). 2023; 12(9).

PMID: 37760051 PMC: 10525666. DOI: 10.3390/antiox12091748.


The Multidirectional Influence of Feed-Borne Deoxynivalenol and Zearalenone on Animal Health.

Gajecki M, Gajecka M Toxins (Basel). 2023; 15(7).

PMID: 37505688 PMC: 10467141. DOI: 10.3390/toxins15070419.

References
1.
Kramer H, van den Ham W, Slob W, Pieters M . Conversion factors estimating indicative chronic no-observed-adverse-effect levels from short-term toxicity data. Regul Toxicol Pharmacol. 1996; 23(3):249-55. DOI: 10.1006/rtph.1996.0050. View

2.
Gonkowski S, Gajecka M, Makowska K . Mycotoxins and the Enteric Nervous System. Toxins (Basel). 2020; 12(7). PMC: 7404981. DOI: 10.3390/toxins12070461. View

3.
Grenier B, Applegate T . Modulation of intestinal functions following mycotoxin ingestion: meta-analysis of published experiments in animals. Toxins (Basel). 2013; 5(2):396-430. PMC: 3640542. DOI: 10.3390/toxins5020396. View

4.
Pastoor T, Bachman A, Bell D, Cohen S, Dellarco M, Dewhurst I . A 21st century roadmap for human health risk assessment. Crit Rev Toxicol. 2014; 44 Suppl 3:1-5. DOI: 10.3109/10408444.2014.931923. View

5.
Piotrowska M, Slizewska K, Nowak A, Zielonka L, Zakowska Z, Gajecka M . The effect of experimental fusarium mycotoxicosis on microbiota diversity in porcine ascending colon contents. Toxins (Basel). 2014; 6(7):2064-81. PMC: 4113742. DOI: 10.3390/toxins6072064. View